Showing results (1-10 of 249) with videos related to

Sort By:
Pageof 25
The Netherlands Journal of Medicine|August 27, 2010
Thalidomide and lenalidomide in primary myelofibrosisN Holle, T de Witte, C Mandigers, et al.
Bone Marrow Transplantation|July 1, 1996
Massive pleural effusion attributed to high-dose cyclophosphamide during conditioning for BMTN Schaap, R Raymakers, A Schattenberg, et al.
Scandinavian Journal of Haematology|November 1, 1985
Repetitive cycles of cytoreductive therapy followed by stem cell autografting for nonlymphoblastic transformation of chronic granulocytic leukaemiaT de Witte, R Raymakers, B de Pauw, et al.
Acta Haematologica|January 1, 1985
Influence of peripheral blood admixture on the number of hematopoietic progenitor cells (CFU-GM and BFU-E) in human bone marrow aspiratesT de Witte, R Holdrinet, R Raymakers, et al.
Leukemia & Lymphoma|June 1, 1994
Prognostic implications of bone marrow culturing in myelodysplastic syndrome: a retrospective analysisR Raymakers, F Preijers, J Boezeman, et al.
Bone Marrow Transplantation|July 25, 1998
Idarubicin to intensify the conditioning regimens of autologous bone marrow transplantation for patients with acute myeloid leukemia in first complete remissionS Jerjis, E Roovers, P Muus, et al.
Bone Marrow Transplantation|April 1, 1997
Outcome of allogeneic bone marrow transplantation with lymphocyte-depleted marrow grafts in adult patients with myelodysplastic syndromesV Mattijssen, A Schattenberg, N Schaap, et al.
Transplantation|February 1, 1984
Bone marrow repopulation capacity after transplantation of lymphocyte-depleted allogeneic bone marrow using counterflow centrifugationT de Witte, R Raymakers, A Plas, et al.
Leukemia|March 1, 1995
Residual normal, highly proliferative progenitors can be isolated from the CD34+/33- fraction of AML with a more differentiated phenotype (CD33+)R Raymakers, S Wittebol, A Pennings, et al.
Leukemia|December 1, 1994
Primitive multilineage progenitor cells predominate in peripheral blood early after mobilization with high-dose cyclophosphamide and GM-CSF or G-CSFS Croockewit, R Raymakers, C Trilsbeek, et al.
Pageof 25